1.4293
Schlusskurs vom Vortag:
$1.44
Offen:
$1.45
24-Stunden-Volumen:
273.07K
Relative Volume:
0.25
Marktkapitalisierung:
$191.90M
Einnahmen:
$108.81M
Nettoeinkommen (Verlust:
$-186.70M
KGV:
-1.6975
EPS:
-0.842
Netto-Cashflow:
$-16.83M
1W Leistung:
-2.77%
1M Leistung:
+10.80%
6M Leistung:
-13.90%
1J Leistung:
+44.78%
Organigram Global Inc Stock (OGI) Company Profile
Compare OGI vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OGI
Organigram Global Inc
|
1.42 | 194.60M | 108.81M | -186.70M | -16.83M | -0.842 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.82 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
114.66 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.05 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.84 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.19 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-07-17 | Fortgesetzt | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-12 | Hochstufung | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | Hochstufung | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-01-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Underperform |
| 2020-01-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-11 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Organigram Global Inc Aktie (OGI) Neueste Nachrichten
Promising Cannabis Stocks To Follow NowMarch 11th - MarketBeat
Organigram Sets March 30 Vote on Sanity Group Acquisition and BAT-Funded Expansion - TipRanks
Canada’s Organigram makes $268M move into German cannabis market - Telegraph-Journal
Fast-Acting Cannabis Shots - Trend Hunter
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting - Business Wire
Organigram Global (NASDAQ:OGI) Stock Price Down 2%Should You Sell? - MarketBeat
Organigram Global Sets March 30 Vote on Transformative Acquisition of Germany’s Sanity Group - TipRanks
Analyst Downgrade: How does Organigram Global Inc correlate with Nasdaq2026 Levels & Daily Chart Pattern Signals - baoquankhu1.vn
Dip Buying: Will Organigram Global Inc outperform its industry peersMarket Performance Summary & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Best Cannabis Stocks To Add to Your WatchlistMarch 5th - MarketBeat
Breakouts Watch: Is Organigram Global Incs ROIC above industry averageJuly 2025 Closing Moves & Safe Capital Growth Plans - baoquankhu1.vn
Organigram Global Expands FAST Platform with Launch of SHRED Shotz Cannabis Product - geneonline.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Organigram Extends SHRED Brand Into Fast-Acting Shot-Sized Cannabis Beverages - TipRanks
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - The AI Journal
Organigram Global Inc. (OGI) Sees C$4 Target on Improved Outlook - Finviz
Organigram Global Moves to Acquire Germany’s Sanity Group in Financed Deal with BAT Support - TipRanks
Organigram (NASDAQ: OGI) to buy Sanity Group and deepen European reach - Stock Titan
OGI PE Ratio & Valuation, Is OGI Overvalued - Intellectia AI
Organigram Global Inc. (OGI) reports Q1 revenue of $97.3 million, with a consensus of $73.15 million - MSN
Document - SEC.gov
What is Organigram Global Inc.’s valuation compared to sectorWeekly Profit Summary & High Accuracy Investment Signals - mfd.ru
Organigram launches 10 SKUs in Australian medical cannabis market - StratCann
Organigram (OGI) launches Edison and BOXHOT medical vapes, pastilles in Australia - Stock Titan
Organigram Expands Global Footprint With New Medical Cannabis Products in Australia - TipRanks
Organigram (OGI) Expands Product Line in Australia with New Laun - GuruFocus
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia - marketscreener.com
Organigram Launches New Products In Australia (NASDAQ:OGI) - Seeking Alpha
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia – Company AnnouncementFT.com - Financial Times
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Organigram Global Moves to Acquire Stake in Germany’s Sanity Group, Expanding European Cannabis Reach - TipRanks
Organigram to buy Berlin-based Sanity Group in €113.4M upfront deal, expanding cannabis supply network - MSN
Analysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and Spyre Therapeutics (SYRE) - The Globe and Mail
BAT (OGI) tightens Organigram partnership with Sanity deal and equity infusion - Stock Titan
Organigram Global (OGI) inks EUR 130M Sanity Group acquisition deal - Stock Titan
Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal - The Globe and Mail
Analyst loves this Canadian pot stock - Cantech Letter
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI) and Qiagen (QGEN) - The Globe and Mail
Organigram Global Inc Strengthens Standards For Consistency TSX Smallcap Index - Kalkine Media
Organigram (OGI) Gains on C$65.2M Investment from British Americ - GuruFocus
Organigram to raise C$65.2 million from BAT for Sanity Group acquisition - Investing.com Nigeria
Alliance Global Partners Reaffirms Their Buy Rating on OrganiGram Holdings (OGI) - The Globe and Mail
BAT boosts Organigram (NASDAQ: OGI) with C$65.2M to fund Sanity buy - Stock Titan
Shareholders Will Be Pleased With The Quality of Organigram Global's (TSE:OGI) Earnings - simplywall.st
BAT Funds $48M for Organigram’s Sanity Group Acquisition - Tobacco Reporter
Cannabis Stocks To Follow TodayFebruary 19th - MarketBeat
Organigram Global Inc. announced that it expects to receive CAD 23.118779 million in funding from BT DE Investments Inc. - marketscreener.com
Canopy, Tilray, Organigram & COMPASS Shift the Landscape - The Dales Report
What's Going On With Organigram Global Stock Thursday? - Benzinga
Small caps to watch: Earnings from MTY Food Group, Organigram’s German acquisition and more - The Globe and Mail
Earnings call transcript: OrganiGram Q1 2026 sees strong revenue growth By Investing.com - Investing.com Nigeria
Finanzdaten der Organigram Global Inc-Aktie (OGI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):